Showing results (181-190 of 253) with videos related to

Sort By:
Pageof 26
Der Urologe. Ausg. A|November 17, 2020
[Practical skills training : How suitable is Peyton's four-step approach for residents in urology?]U Necknig, A Buchner, H Leyh, et al.
European Urology|February 6, 1999
Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancerH Leyh, M Marberger, P Conort, et al.
Archives of Environmental Health|June 1, 1975
Lead. Possible toxicity in urban vs rural ratsD Mouw, K Kalitis, M Anver, et al.
Helvetica Chirurgica Acta|August 1, 1981
[Detection of urinary organic acids by gradual titration of pH 2,0-7,4. Significance for the assessment of the litho-protective characteristic of the examined urine]P Leskovar, R Hartung, M Hropot, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 17, 1998
Erythema after laser skin resurfacingJ Ruiz-Esparza, J M Barba Gomez, O L Gomez de la Torre, et al.
International Journal of Immunopathology and Pharmacology|October 6, 2004
Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abeta(1-42)-induced brain inflammation and neuronal damage in the ratC Prosperi, C Scali, M Barba, et al.
The Journal of Urology|January 13, 2006
Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once dailyR Hartung, H Matzkin, A Alcaraz, et al.
Urologia Internationalis|January 1, 1987
[Morphologic examination of the urothelium after irradiation with laser energy]R Hofmann, R Hartung, K Geissdörfer, et al.
Urological Research|May 1, 1993
Inhibitory effects on in vitro cell growth of human urothelial tumor cell lines under the combined administration of hematopoietic growth factors and clinically relevant antineoplastic agentsT Block, U Treiber, B Geffken, et al.
The Cochrane Database of Systematic Reviews|April 22, 2008
Anticoagulation for the long term treatment of venous thromboembolism in patients with cancerE A Akl, M Barba, S Rohilla, et al.
Pageof 26